Last reviewed · How we verify
Daricon (OXYPHENCYCLIMINE)
Daricon (Oxyphencyclimine) is a small molecule drug that targets the muscarinic acetylcholine receptor M1. It is classified as an oxyphencyclimine and is used to treat peptic ulcers. As an off-patent medication, Daricon is no longer protected by active patents, making it available as a generic option. However, there are currently no generic manufacturers listed. This medication's commercial status and availability may vary depending on the region and market.
At a glance
| Generic name | OXYPHENCYCLIMINE |
|---|---|
| Drug class | oxyphencyclimine |
| Target | Muscarinic acetylcholine receptor M1 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
- Peptic ulcer
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |